The bromodomain BET inhibitor JQ1 suppresses tumor angiogenesis in models of childhood sarcoma

Pharmacology, Toxicology and Pharmaceutical Science

• Sarcoma 100%
• Antitumor Activity 100%
• Neoplasm 50%
• Vasculotropin 50%
• Angiogenesis Inhibitor 50%
• Solid Malignant Neoplasm 50%
• Protein 50%
• Element 50%
• Tumor Model 50%
• Matrigel 50%
• Tumor Vascularization 50%
• Mouse 50%
• Drug 50%
• Rhabdomyosarcoma 50%
• Minoxidil 50%
• Antiangiogenic 50%
• Hematologic Malignancy 50%
• Ewing Sarcoma 50%
• Bromodomain Inhibitor 50%
• Cell Proliferation 50%
• Growth Factor 50%

Biochemistry, Genetics and Molecular Biology

• Antineoplastic Activity 100%
• Bromodomain 100%
• Childhood 100%
• down Regulation 50%
• Cell Proliferation 50%
• Solid 50%
• Vascularization 50%
• Angiogenesis 50%
• Enantiomer 50%
• Mouse 50%
• Growth 50%
• Antiangiogenic Activity 50%
• Ewing's Sarcoma 50%
• Protein 50%
• Tumor Vascularization 50%
• Vascular Endothelial Growth Factor 50%
• FOSL1 50%